Skip to content
  • Home
  • About
  • Contact
  • Services
  • Advertise with Us
US Pharma Marketing Logo

US Pharma Marketing

  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A

Author: Jayshree Gondane

Jayshree Gondane, BHMS student and healthcare enthusiast with a genuine interest in medical sciences, patient well-being, and the real-world workings of the healthcare system.
Top 5 Reasons Biotech Companies Fail to Scale
Posted in
  • Case Studies & Trends
  • Industry Landscape
  • Regulatory Compliance

Top 5 Reasons Biotech Companies Fail to Scale

Biotechnology has emerged as one of the most innovation-driven sectors in healthcare. Advances in gene therapy, … Top 5 Reasons Biotech Companies Fail to ScaleRead more

by Jayshree Gondane•February 23, 2026February 23, 2026•0
Why Pricing Pressure Is Reshaping Drug Commercialization
Posted in
  • Industry Landscape
  • Regulatory Compliance

Why Pricing Pressure Is Reshaping Drug Commercialization

The United States pharmaceutical market has historically provided manufacturers with substantial pricing flexibility compared to other … Why Pricing Pressure Is Reshaping Drug CommercializationRead more

by Jayshree Gondane•February 23, 2026February 23, 2026•0
How Market Access Challenges Detail Pharma Growth
Posted in
  • Industry Landscape
  • Strategy & Execution

How Market Access Challenges Detail Pharma Growth

The United States pharmaceutical industry is one of the most advanced and competitive healthcare markets in … How Market Access Challenges Detail Pharma GrowthRead more

by Jayshree Gondane•February 23, 2026February 23, 2026•0
How Data Silos Hurt Pharma Innovation
Posted in
  • Case Studies & Trends
  • Digital Transformation

How Data Silos Hurt Pharma Innovation

Over 70% of pharmaceutical R&D data in the United States remains siloed, according to PhRMA (https://phrma.org). … How Data Silos Hurt Pharma InnovationRead more

by Jayshree Gondane•February 22, 2026February 22, 2026•0
Why Many Drugs Fail Despite Positive Trial Results
Posted in
  • Case Studies & Trends
  • Regulatory Compliance

Why Many Drugs Fail Despite Positive Trial Results

Over 90 percent of drugs that show promise in early-phase clinical trials fail to reach the … Why Many Drugs Fail Despite Positive Trial ResultsRead more

by Jayshree Gondane•February 22, 2026February 22, 2026•0
How AI Can Improve Clinical Trial Design and Outcomes
Posted in
  • Digital Transformation
  • Industry Landscape
  • Strategy & Execution

How AI Can Improve Clinical Trial Design and Outcomes

Clinical trials are the most expensive, time-consuming, and failure-prone phase of drug development. Despite advances in … How AI Can Improve Clinical Trial Design and OutcomesRead more

by Jayshree Gondane•February 21, 2026February 21, 2026•0
Why Pharma Sales Teams Struggle in a Digital-First World
Posted in
  • Digital Transformation
  • Industry Landscape
  • Strategy & Execution

Why Pharma Sales Teams Struggle in a Digital-First World

The pharmaceutical industry has long relied on in-person interactions between sales representatives and healthcare professionals to … Why Pharma Sales Teams Struggle in a Digital-First WorldRead more

by Jayshree Gondane•February 21, 2026February 21, 2026•0
Why Clinical Trials Are Becoming Harder to Recruit For
Posted in
  • Case Studies & Trends

Why Clinical Trials Are Becoming Harder to Recruit For

Clinical trials are the backbone of pharmaceutical innovation. Every approved therapy in the United States has … Why Clinical Trials Are Becoming Harder to Recruit ForRead more

by Jayshree Gondane•February 21, 2026February 21, 2026•0
The Hidden Costs of Failed Clinical Trials
Posted in
  • Strategy & Execution

The Hidden Costs of Failed Clinical Trials

Clinical trial failure is often framed as a scientific setback – a missed endpoint, an unexpected … The Hidden Costs of Failed Clinical TrialsRead more

by Jayshree Gondane•February 21, 2026February 21, 2026•0
Why Patient Education Is Critical for Pharma Commercial Success
Posted in
  • Case Studies & Trends
  • Sponsored

Why Patient Education Is Critical for Pharma Commercial Success

Patient education is no longer an optional aspect of pharmaceutical marketing—it is central to commercial success. … Why Patient Education Is Critical for Pharma Commercial SuccessRead more

by Jayshree Gondane•February 19, 2026February 19, 2026•0

Posts pagination

Previous 1 2 3 … 15 Next

Recent Posts

  • Why Pharma Companies Overinvest in Sales and Underinvest in Strategy
  • Top 7 Go-To-Market Mistakes in Pharma Launches
  • How to Become a Pharmaceutical Sales Representative
  • Virtual Reality in Pharma Sales Training
  • How to Use QR Codes in Pharmaceutical Marketing

Recent Comments

No comments to show.
Copyright © 2026 US Pharma Marketing.
Powered by WordPress and HybridMag.
  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A